ADCs Continue to Make First-Line Inroads in Triple-Negative Breast Cancer
(MedPage Today) -- Antibody-drug conjugates (ADCs) are becoming an increasingly relevant first-line treatment option for metastatic triple-negative breast cancer (TNBC). "ADCs are a fairly old class…
Read the full article15h agoen
You might also wanna read
Should you eat like Erling Haaland? Doctors say follow his food philosophy, not his 6,000-calorie diet
news9live.com·8m ago
King's College London study identifies novel mechanism of brain cell death in Alzheimer's disease
sciencealert.com·22m ago
Dementia rates among elderly Americans are declining, research shows
economist.com·1h ago
Chandipura virus outbreak in Gujarat fresh child deaths: Symptoms, treatment, prevention and everything you need to know
news9live.com·1h ago
How extreme heat impairs cognitive function and mental health: What researchers know so far
technologyreview.com·1h ago
NPPA announces price cap on 30 medicines including diabetes, hypertension and cardiac drugs; check full list here
news9live.com·1h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.